CNSY Cerenome, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$1.60
· of 52w range
· above low
· to high
$1.5452w low
$4.1652w high
Market Cap (MRQ)
$12M
your badges
52W Range
$2–$4
Analyst Rating
BUY
Price Target
$28
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
CNSY Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.60
Market Cap (MRQ)
$12M
52W Range
$2–$4
CNSY Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| April 2, 2026 | 1-for-25 | Reverse |
| May 1, 2023 | 1-for-15 | Reverse |
| Aug. 6, 2019 | 1-for-50 | Reverse |
| May 24, 2018 | 1-for-10 | Reverse |
| May 12, 2016 | 1-for-15 | Reverse |
About Cerenome, Inc. - Common Stock Company overview from Wikipedia
sector·
industry·
employees28
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CNSY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 2.1 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CNSY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.4 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-11.5%
Next Report
Oct 28, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-1.31 | $-0.93 | -41.1% |
| March 31, 2026 | $-1.05 | $-0.90 | -17.0% | |
| Dec. 31, 2025 | $-1.04 | $-0.83 | -25.2% | |
| Sept. 30, 2025 | $-1.00 | $-0.51 | -96.1% | |
| June 30, 2025 | $0.50 | $-2.29 | 121.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
No annual filings for CNSY
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q2 2026 |
|---|---|---|
| Revenue | $411.0K | |
| R&D Expense | $4M | |
| SG&A Expense | $5M | |
| Operating Expenses | $9M | |
| Operating Income | $-9M | |
| Interest Income | $56.0K | |
| Other Non-op | $51.0K | |
| Net Income | $-9M | |
| EPS (Basic) | $-1.31 | |
| EPS (Diluted) | $-1.31 | |
| Shares (Basic) | 6,898,804 | |
| Shares (Diluted) | 6,898,804 | |
| EBITDA | $-9M |
Balance Sheet
| Metric | Trend | Q2 2026 |
|---|---|---|
| Cash & Equivalents | $2M | |
| Short-term Investments | $6M | |
| Other Current Assets | $1M | |
| Current Assets | $12M | |
| PP&E (Net) | $1M | |
| Goodwill | $372.0K | |
| Other Non-current Assets | $170.0K | |
| Total Assets | $14M | |
| Accounts Payable | $8M | |
| Current Liabilities | $9M | |
| Total Liabilities | $9M | |
| Common Stock | $7.0K | |
| Paid-in Capital | $538M | |
| Retained Earnings | $-532M | |
| Treasury Stock | $500.0K | |
| Stockholders' Equity | $5M | |
| Liabilities + Equity | $14M | |
| Shares Outstanding | 7,310,008 |
Cash Flow
| Metric | Trend | Q2 2026 |
|---|---|---|
| D&A | $137.0K | |
| Stock-based Comp | $830.0K | |
| Operating Cash Flow | $-7M | |
| CapEx | $499.0K | |
| Investing Cash Flow | $5M | |
| Financing Cash Flow | $1M | |
| Net Change in Cash | $-656.0K |
Profitability
| Metric | Trend | Q2 2026 |
|---|---|---|
| Operating Margin | -2203.7% | |
| Net Margin | -2191.2% | |
| EBITDA Margin | -2203.7% | |
| ROA | -73.9% | |
| ROE | -212.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 |
|---|---|---|
| Current Ratio | 1.4 | |
| Quick Ratio | 1.0 |
Efficiency
| Metric | Trend | Q2 2026 |
|---|---|---|
| Asset Turnover | 0.0 |
Per Share
| Metric | Trend | Q2 2026 |
|---|---|---|
| Book Value / Share | $0.75 | |
| Revenue / Share | $0.06 | |
| Cash / Share | $0.32 | |
| EPS (TTM) | $-1.45 |
Valuation (TTM)
| Metric | Trend | Q2 2026 |
|---|---|---|
| Revenue TTM | $4M | |
| Net Income TTM | $-26M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Company insiders 7 insiders · 2 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Marc H Hedrick | Chief Executive Officer | Oct. 1, 2026 M | 60,922 | 0 | 0 | $0 |
| Andrew John Hugh Macintyre Sims | Chief Financial Officer | Oct. 1, 2026 M | 12,926 | 0 | 0 | $0 |
| Howard Clowes | Director | Oct. 1, 2026 M | 2,902 | 0 | 0 | $0 |
| An Van Es-Johansson | Director | Oct. 1, 2026 M | 1,843 | 0 | 0 | $0 |
| Kyle Guse | Director | Oct. 1, 2026 M | 1,843 | 0 | 0 | $0 |
| Richard J Hawkins | Director | Oct. 1, 2026 M | 2,450 | 0 | 0 | $0 |
| Ronald Asbury Andrews | Director | Oct. 1, 2026 M | 1,843 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.00% | 28,103 SH | Sept. 11, 2026 | Daily |
CNSY Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$28.00
+1650.0%
2 20.0%
Strong Buy
7 70.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-10-02Mean target $27.75 +1634.4%
← Below all targets
Current price $1.60
Low$12.00
Mean$27.75
High$43.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CNSY | · | · | · | · | · | · |
| PTN | $19M | -3.6 | -7.5% | -111.7% | -92.3% | · |
| BCDA | $13M | · | -87.8% | · | 1660.5% | · |
| AKTX | $26.17B | · | · | · | -64.1% | · |
| VTGN | · | -0.3 | 161.1% | -5491.3% | -136.8% | · |
| PASG | $38M | -0.8 | · | · | -159.7% | · |
| INAB | $23M | -0.5 | · | · | -90.8% | · |
| LSTA | · | -1.0 | -83.0% | · | · | · |
| TPST | $14M | -0.5 | · | · | -319.3% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026